• Profile
Close

Longitudinal cognitive biomarkers predicting symptom onset in presymptomatic frontotemporal dementia

Journal of Neurology Apr 13, 2018

Jiskoot LC, et al. - Experts examined the cognitive decline and the prognostic abilities from presymptomatic to symptomatic familial frontotemporal dementia (FTD) in a 4-year follow-up neuropsychological analysis. A mutation-specific pattern of cognitive decline was identified via longitudinal neuropsychological assessment. This indicated a potential prognostic value of neuropsychological trajectories in conversion to symptomatic FTD.

Methods

  • Neuropsychological assessment was carried out in presymptomatic MAPT (n = 15) and GRN mutation carriers (n = 31), and healthy controls (n = 39) every 2 years.
  • A total of 8 mutation carriers (5 MAPT, 3 GRN) became symptomatic.
  • Cognitive decline via multilevel regression modeling was evaluated, along with the prognostic performance via ROC analyses and stepwise logistic regression.

Results

  • A decline was reported in the MAPT converters on language, attention, executive function, social cognition, and memory, while GRN converters declined on attention and executive function (p <0.05).
  • As per the outcomes, cognitive decline in ScreeLing phonology (p=0.046) and letter fluency (p=0.046) predicted conversion to non-fluent variant PPA and decline on categorical fluency (p=0.025) for an underlying MAPT mutation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay